Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC Exosomes and Mitochondria in CABG
NCT05669144Phase 2Unknown
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2022
- Primary completion
- Sep 2023
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cell exosomes in heart failure (HF), myocardial infarction (MI), Myocardial ischemia (MI), Myocardial stunning, sponsored by Tehran University of Medical Sciences. Status: unknown.
02
Drugs
mesenchymal stem cell exosomes
03
Conditions
heart failure (HF)myocardial infarction (MI)Myocardial ischemia (MI)Myocardial stunning
Beyond the preview
Go deeper on NCT05669144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05669144.